Your browser doesn't support javascript.
loading
Nrf2 activation reprograms macrophage intermediary metabolism and suppresses the type I interferon response.
Ryan, Dylan G; Knatko, Elena V; Casey, Alva M; Hukelmann, Jens L; Dayalan Naidu, Sharadha; Brenes, Alejandro J; Ekkunagul, Thanapon; Baker, Christa; Higgins, Maureen; Tronci, Laura; Nikitopolou, Efterpi; Honda, Tadashi; Hartley, Richard C; O'Neill, Luke A J; Frezza, Christian; Lamond, Angus I; Abramov, Andrey Y; Arthur, J Simon C; Cantrell, Doreen A; Murphy, Michael P; Dinkova-Kostova, Albena T.
Afiliação
  • Ryan DG; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
  • Knatko EV; Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK.
  • Casey AM; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, James Arrott Drive, Dundee, Scotland, UK.
  • Hukelmann JL; Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.
  • Dayalan Naidu S; Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Brenes AJ; Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Ekkunagul T; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, James Arrott Drive, Dundee, Scotland, UK.
  • Baker C; Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Higgins M; Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Tronci L; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, James Arrott Drive, Dundee, Scotland, UK.
  • Nikitopolou E; Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Honda T; Division of Cellular Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, James Arrott Drive, Dundee, Scotland, UK.
  • Hartley RC; Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK.
  • O'Neill LAJ; Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK.
  • Frezza C; Department of Chemistry and Institute of Chemical Biology & Drug Discovery, Stony Brook University, Stony Brook, NY, USA.
  • Lamond AI; School of Chemistry, University of Glasgow, Glasgow, UK.
  • Abramov AY; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
  • Arthur JSC; Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK.
  • Cantrell DA; Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
  • Murphy MP; Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, London, UK.
  • Dinkova-Kostova AT; Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
iScience ; 25(2): 103827, 2022 Feb 18.
Article em En | MEDLINE | ID: mdl-35198887
ABSTRACT
To overcome oxidative, inflammatory, and metabolic stress, cells have evolved cytoprotective protein networks controlled by nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) and its negative regulator, Kelch-like ECH associated protein 1 (Keap1). Here, using high-resolution mass spectrometry we characterize the proteomes of macrophages with altered Nrf2 status revealing significant differences among the genotypes in metabolism and redox homeostasis, which were validated with respirometry and metabolomics. Nrf2 affected the proteome following lipopolysaccharide (LPS) stimulation, with alterations in redox, carbohydrate and lipid metabolism, and innate immunity. Notably, Nrf2 activation promoted mitochondrial fusion. The Keap1 inhibitor, 4-octyl itaconate remodeled the inflammatory macrophage proteome, increasing redox and suppressing type I interferon (IFN) response. Similarly, pharmacologic or genetic Nrf2 activation inhibited the transcription of IFN-ß and its downstream effector IFIT2 during LPS stimulation. These data suggest that Nrf2 activation facilitates metabolic reprogramming and mitochondrial adaptation, and finetunes the innate immune response in macrophages.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article